Theravance Biopharma Inc ( TBPH) - Stock Earnings
TBPH Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 10, 2026, midnight | — / — | — | — / — | — |
TBPH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 61.0 million USD | 45.9 million USD |
| 2026Q1 | -4.9 million USD | 17.7 million USD |
| 2026Q2 | -5.9 million USD | 20.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TBPH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -55.2 million USD | 57.4 million USD |
| 2024 | -56.4 million USD | 64.4 million USD |
| 2025 | 105.9 million USD | 107.5 million USD |
| 2026 Est. | — | — |
TBPH
Price: $17.03
Earnings Per Share: 1.04 USD
P/E Ratio: 16.32
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Cayman Islands
Volume: 260600
Ebitda: -62.9 millionMarket Capitalization: 882.6 million